Ground-breaking glycocalyx study could improve cancer immunotherapy
The researchers found that cancer cells with thicker glycocalyx barrier are better at evading immune cells.
List view / Grid view
The researchers found that cancer cells with thicker glycocalyx barrier are better at evading immune cells.
Tune into this podcast to hear experts discussing scaling up 3D organoids!
The PSMA Protein is a new therapeutic hot target. In this article, learn about its growing role in the fight against prostate cancer and beyond.
Watch Dr David Rimm from the Yale School of Medicine talk about his recent work and take on the future of multiplex spatial profiling of the TME.
Tune into this podcast to hear experts discuss imaging and analysing data from organoids!
US scientists have outlined the structure and function of the first FDA approved drug for the Ebola virus.
A guide for advanced and quantitative life science applications.
Streamline oncology therapeutic development with CST® recombinant monoclonal antibodies, ELISA & cellular assay kits, & custom products & services.
30 January 2023 | By Thermo Fisher Scientific
Watch this webinar to learn how an integrated structural biology workflow can be used to get crucial structural insights on key protein targets that are of therapeutic interest.
Scientists from Rice University are using fluorescence lifetime to shed new light on a peptide associated with Alzheimer’s disease.
US researchers will use a unique combination of imaging techniques (MRI and MSI) to study Alzheimer’s disease on a scale that has never been done before.
US researchers use new imaging technique to see cardiac reactions to noradrenaline, the ‘fight or flight’ hormone.
Tune into this podcast to hear experts discuss imaging and obtaining data from organoids!
Performing live-cell correlative light and electron microscopy (CLEM) with Coral Life.
Advance your neurodegeneration research with our broad antibody portfolio, ready-to-use ELISA, and cellular kits to develop new efficacious therapies.